title: Scotland's national naloxone program: The prison experience.
abstract: Launched in 2011, the Scottish national naloxone program marked an important development in public health policy. Central to its design were strategies to engage prisoners given their elevated risk of drug-related death in the weeks following liberation. Implementation across Scottish prisons has posed particular challenges linked to both operational issues within prison establishments and individual factors affecting staff delivering, and prisoners engaging, with the program. Barriers have been overcome through innovation and partnership working. This commentary has described how the development of the program in prisons has adapted to these challenges to a point where a largely consistent model is in place and where prisoners-on-release are reaping the benefits in terms of reduced opioid-related mortality.
authors.affiliation: Scottish Drugs Forum, Glasgow, UK.
authors.forename: Kirsten
authors.initials: K
authors.lastname: Horsburgh
authors.affiliation: Blood Borne Viruses and Sexually Transmitted Infections Team, Health Protection Scotland, National Health Services Scotland, Glasgow, UK.|School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: McAuley
mesh_terms: D062787:Drug Overdose / Q000188:drug therapy*; D040261:Harm Reduction; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D011329:Prisoners; D011330:Prisons; D012606:Scotland
chemical_list: D009292:Narcotic Antagonists; D009270:Naloxone
keywords: mortality; naloxone; overdose; prison